Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2021-01-13
REPLReplimune Group, Inc.Franchi Jean M.CFOS - Sale+OE$44.53-15,0000-100%-$667,884
2021-01-14
PASGPassage Bio, Inc.Quigley Jill M.COOS - Sale$30.10-16,298297,584-5%-$490,570
M
2021-01-14
SURFSurface Oncology, Inc.Ross Robert W.Chief Medical OfficerS - Sale$12.02-9,00089,000-9%-$108,150
DM
2021-01-13
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale+OE$64.42-30,0000-100%-$1,932,594
D
2021-01-14
ADPTAdaptive Biotechnologies CorpGriffin Michelle ReneeDirS - Sale+OE$65.88-6,0000-100%-$395,253
D
2021-01-15
SGENSeagen Inc.Liu Jean IGC, EVP, Leg AffairsS - Sale+OE$180.00-5,00060,266-8%-$900,000
D
2021-01-13
ADPTAdaptive Biotechnologies CorpCohen Chad MCFOS - Sale+OE$63.41-50,0001,000-98%-$3,170,268
M
2021-01-13
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$117.08-20,00023,350,0560%-$2,341,600
D
2021-01-12
BDTXBlack Diamond Therapeutics, Inc.Hatzis-Schoch BrentSee RemarksS - Sale+OE$34.03-11,5788,400-58%-$394,041
M
2021-01-12
RLAYRelay Therapeutics, Inc.Third Rock Ventures Iii, L.P.10%S - Sale$40.40-5,622,3947,739,918-42%-$227,132,712
D
2021-01-12
EXELExelixis, Inc.Senner Christopher J.EVP, CFOS - Sale+OE$25.00-30,000248,319-11%-$750,000
DM
2021-01-12
RGNXRegenxbio Inc.Simpson CurranChief Oper., Tech. OfficerS - Sale+OE$50.01-13,31217,748-43%-$665,767
M
2021-01-12
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$50.02-15,293113,892-12%-$765,025
D
2021-01-13
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$235.99-1,00015,805-6%-$235,990
2021-01-12
VYGRVoyager Therapeutics, Inc.Turenne AndrePres, CEOS - Sale$8.62-10,443156,352-6%-$90,019
2021-01-12
VYGRVoyager Therapeutics, Inc.Dorval AllisonCFOS - Sale$8.62-2,94249,080-6%-$25,360
D
2021-01-12
CGEMCullinan Management, Inc.Ubs Oncology Impact Fund L.P.10%P - Purchase$21.00+300,0007,913,887+4%+$6,300,000
D
2021-01-12
CGEMCullinan Management, Inc.Gadicke AnsbertDir, 10%P - Purchase$21.00+300,0008,195,155+4%+$6,300,000
D
2021-01-12
CGEMCullinan Management, Inc.Jovan-Embiricos MoranaDir, 10%P - Purchase$21.00+200,000217,269>999%+$4,200,000
2021-01-12
CGEMCullinan Management, Inc.Hughes OwenPres, CEOP - Purchase$21.00+2,500506,2260%+$52,500
2021-01-12
CGEMCullinan Management, Inc.Trigilio JeffreyCFOP - Purchase$21.00+2,2502,250New+$47,250
2021-01-12
TWSTTwist Bioscience CorpLeproust Emily M.Pres, CEOS - Sale$166.88-2,000431,1960%-$333,751
DM
2021-01-12
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$122.15-20,0001,795,646-1%-$2,443,000
M
2021-01-11
PCVXVaxcyte, Inc.Hopfner Robert LorneDirS - Sale$26.29-97,3431,980,012-5%-$2,558,948
D
2021-01-12
ADPTAdaptive Biotechnologies CorpCohen Chad MCFOS - Sale+OE$62.59-75,0001,000-99%-$4,694,543
DM
2021-01-11
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale+OE$61.93-30,0000-100%-$1,857,960
D
2021-01-12
VIRVir Biotechnology, Inc.Virgin HerbertEVP, Research, CSOS - Sale+OE$29.36-3,80533,200-10%-$111,696
D
2021-01-11
TECHBio-Techne CorpHippel JamesCFOS - Sale+OE$333.63-10,0009,137-52%-$3,336,322
D
2021-01-11
NSTGNanostring Technologies IncMalloy KirkDirS - Sale+OE$66.53-2,500990-72%-$166,325
D
2021-01-12
NKNantkwest, Inc.Nelson SonjaCFOS - Sale+OE$15.00-16,36415,410-52%-$245,460
2021-01-12
EDITEditas Medicine, Inc.Robertson MichelleCFOS - Sale$78.27-1,56818,432-8%-$122,727
D
2021-01-11
PCVXVaxcyte, Inc.Sauer PaulSVP Process Dev, ManufacturingS - Sale+OE$26.21-2,50077,899-3%-$65,527
2021-01-12
ADAPAdaptimmune Therapeutics PlcBertrand William C JrCOOS - Sale$6.15-2,2343,768-37%-$13,744
2021-01-12
ADAPAdaptimmune Therapeutics PlcLunger JohnChief Patient Supply OfficerS - Sale$6.15-1,0581,767-37%-$6,509
2021-01-12
ADAPAdaptimmune Therapeutics PlcNorry ElliotChief Medical OfficerS - Sale$6.15-8411,396-38%-$5,174
2021-01-12
ADAPAdaptimmune Therapeutics PlcRawcliffe AdrianCEOS - Sale$6.15-2,7073,695-42%-$16,654
M
2021-01-08
FATEFate Therapeutics IncWolchko J ScottPres, CEOS - Sale$116.33-69,407350,562-17%-$8,073,772
M
2021-01-08
FATEFate Therapeutics IncValamehr BahramChief Development OfficerS - Sale$114.94-9,48477,727-11%-$1,090,140
M
2021-01-08
FATEFate Therapeutics IncTahl CindyGC, SecretaryS - Sale$114.94-9,48390,035-10%-$1,090,021
M
2021-01-08
FATEFate Therapeutics IncShoemaker Daniel DChief Scientific OfficerS - Sale$114.94-9,48283,609-10%-$1,089,911
D
2021-01-12
IDRAIdera Pharmaceuticals, Inc.Kirby John J.CFOS - Sale+OE$4.22-1,69333,882-5%-$7,152
D
2021-01-12
IDRAIdera Pharmaceuticals, Inc.Tarka Elizabeth AnnChief Medical OfficerS - Sale+OE$4.19-1,74518,255-9%-$7,310
D
2021-01-12
IDRAIdera Pharmaceuticals, Inc.Lim Bryant DavidSVP, GCS - Sale+OE$4.21-1,71138,064-4%-$7,202
D
2021-01-12
IDRAIdera Pharmaceuticals, Inc.Milano VincentPres, CEOS - Sale+OE$4.20-3,210208,611-2%-$13,474
M
2021-01-08
CABACabaletta Bio, Inc.5Am Ventures V, L.P.10%S - Sale$13.00-387,000369,688-51%-$5,031,000
DM
2021-01-08
RGNXRegenxbio Inc.Christmas Patrick J.GCS - Sale+OE$48.14-21,50016,372-57%-$1,035,082
D
2021-01-11
MRNAModerna, Inc.Andres JuanSee remarksS - Sale+OE$112.83-5,0000-100%-$564,150
D
2021-01-11
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$117.12-5,0000-100%-$585,586
2021-01-08
NBIXNeurocrine Biosciences IncRoberts EiryChief Medical OfficerS - Sale$111.06-2,63215,845-14%-$292,297
D
2021-01-08
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale+OE$110.22-308,250441,071-41%-$33,973,877
D
2021-01-08
FATEFate Therapeutics IncRedmile Group, LLCDir, 10%P - Purchase$85.50+327,48512,957,222+3%+$27,999,968
D
2021-01-08
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale+OE$60.45-15,0000-100%-$906,777
2021-01-05
IDRAIdera Pharmaceuticals, Inc.Lim Bryant DavidSVP, GCS - Sale$3.91-1,46539,775-4%-$5,722
2021-01-05
IDRAIdera Pharmaceuticals, Inc.Milano VincentPres, CEOS - Sale$3.91-2,740211,821-1%-$10,700
2021-01-08
EIGREiger Biopharmaceuticals, Inc.Mayer Eldon C. IIIEx VP, Chief Commerc. OfficerS - Sale$11.68-1,69035,810-5%-$19,739
D
2021-01-08
BDTXBlack Diamond Therapeutics, Inc.Leggett ThomasCFOS - Sale+OE$33.94-3,0000-100%-$101,820
D
2021-01-07
RGNXRegenxbio Inc.Simpson CurranChief Oper., Tech. OfficerS - Sale+OE$50.01-5,18517,748-23%-$259,302
M
2021-01-07
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$49.06-16,239129,185-11%-$796,615
D
2021-01-07
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$50.01-1,500281,984-1%-$75,015
2021-01-08
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$114.02-11,04623,370,0560%-$1,259,500
M
2021-01-07
JNCEJounce Therapeutics, Inc.Trehu ElizabethChief Medical OfficerS - Sale$6.89-5,29871,335-7%-$36,498
M
2021-01-07
JNCEJounce Therapeutics, Inc.Murray Richard /ca/CEO, PresS - Sale$6.89-21,999140,371-14%-$151,549
M
2021-01-07
JNCEJounce Therapeutics, Inc.Drapkin Kimberlee CCFO, TreasurerS - Sale$6.89-5,82755,881-9%-$40,142
M
2021-01-07
JNCEJounce Therapeutics, Inc.Cole Hugh MChief Business OfficerS - Sale$6.89-6,21955,189-10%-$42,842
D
2021-01-07
SGENSeagen Inc.Siegall Clay BPres, CEOS - Sale+OE$172.44-29,353715,209-4%-$5,061,681
M
2021-01-05
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale$45.05-10,428255,962-4%-$469,783
2021-01-06
BLUEBluebird Bio, Inc.Baird William D IIICFOS - Sale$45.05-94922,797-4%-$42,756
M
2021-01-05
BLUEBluebird Bio, Inc.Finger Alison CecilyChief Commercial OfficerS - Sale$45.05-1,85425,103-7%-$83,525
M
2021-01-05
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale$45.05-3,21536,361-8%-$144,841
M
2021-01-05
BLUEBluebird Bio, Inc.Cole JasonCOO andS - Sale$45.05-2,40132,823-7%-$108,169
M
2021-01-05
BLUEBluebird Bio, Inc.Smith-Farrell JoanneCOO, OncologyS - Sale$45.05-1,32920,609-6%-$59,872
M
2021-01-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale$45.05-2,79933,007-8%-$126,100
M
2021-01-06
PCVXVaxcyte, Inc.Hopfner Robert LorneDirS - Sale$28.30-145,6122,077,355-7%-$4,120,277
M
2021-01-06
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$115.72-19,00023,381,1020%-$2,198,640
DM
2021-01-05
NVAXNovavax IncTrizzino JohnEVP, CMO, CBOS - Sale+OE$112.34-17,913287-98%-$2,012,353
DM
2021-01-04
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale+OE$56.58-30,0000-100%-$1,697,386
DM
2021-01-06
ADPTAdaptive Biotechnologies CorpRubinstein JuliePresS - Sale+OE$56.10-30,0000-100%-$1,682,877
D
2021-01-05
TWSTTwist Bioscience CorpFinn Patrick JohnChief Commercial OfficerS - Sale+OE$132.93-2,70244,228-6%-$359,177
D
2021-01-04
EXELExelixis, Inc.Lamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$20.32-65,000300,229-18%-$1,320,800
D
2021-01-04
NKNantkwest, Inc.Nelson SonjaCFOS - Sale+OE$13.62-39,27120,410-66%-$534,938
D
2021-01-04
ADPTAdaptive Biotechnologies CorpDobmeier EricDirS - Sale+OE$57.34-10,0000-100%-$573,369
D
2021-01-04
ADPTAdaptive Biotechnologies CorpBenzeno SharonChief Business Development OffS - Sale+OE$57.39-6,7710-100%-$388,583
2021-01-05
XLRNAcceleron Pharma IncVeness Adam MSVP, GC, Sec.S - Sale$122.56-2,05616,163-11%-$251,988
2021-01-04
XLRNAcceleron Pharma IncKango SujayEVP, Chief Commercial OfficerS - Sale$125.38-10,0003,987-71%-$1,253,759
M
2021-01-04
MGTXMeiragtx Holdings PlcNaylor StuartChief Development OfficerS - Sale$15.37-12,000438,017-3%-$184,440
A
2020-11-10
MGTXMeiragtx Holdings PlcNaylor StuartChief Development OfficerS - Sale$15.00-4,851450,017-1%-$72,765
M
2021-01-04
XLRNAcceleron Pharma IncMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$123.24-4,7795,813-45%-$588,974
2021-01-05
XLRNAcceleron Pharma IncDable Habib JCEO, PresS - Sale$121.13-4,25881,788-5%-$515,774
D
2021-01-04
DNLIDenali Therapeutics Inc.Schuth Alexander O.COO, SecretaryS - Sale+OE$74.95-70,000555,248-11%-$5,246,408
D
2021-01-04
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale+OE$74.96-88,3342,322,978-4%-$6,621,782
D
2021-01-04
BDTXBlack Diamond Therapeutics, Inc.Roberts Christopher D.Chief Scientific OfficerS - Sale+OE$31.41-2,5003,200-44%-$78,525
D
2021-01-04
HARPHarpoon Therapeutics, Inc.Wesche HolgerChief Scientific OfficerS - Sale+OE$18.38-10,00052,852-16%-$183,837
D
2021-01-04
BDTXBlack Diamond Therapeutics, Inc.Epstein David M.See RemarksS - Sale+OE$31.13-12,000961,569-1%-$373,505
2021-01-05
IDRAIdera Pharmaceuticals, Inc.Kirby John J.CFOS - Sale$3.90-86235,575-2%-$3,362
2021-01-04
RGENRepligen CorpSnodgres JonCFOS - Sale$191.52-3,95729,498-12%-$757,840
2020-12-31
SGMOSangamo Therapeutics, IncRamelmeier Rolf AndrewEVP, Technical OperationsS - Sale$16.74-2,46465,978-4%-$41,247
2021-01-05
XFORX4 Pharmaceuticals, IncRagan PaulaPres, CEOS - Sale$7.00-2,400277,723-1%-$16,800
2021-01-04
ADAPAdaptimmune Therapeutics PlcLunger JohnChief Patient Supply OfficerS - Sale$5.33-1,0651,760-38%-$5,674
2021-01-04
ADAPAdaptimmune Therapeutics PlcBertrand William C JrCOOS - Sale$5.33-3,4995,864-37%-$18,642
2021-01-04
ADAPAdaptimmune Therapeutics PlcNorry ElliotChief Medical OfficerS - Sale$5.33-8451,392-38%-$4,502

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top